Live Breaking News & Updates on Navidea Biopharmaceuticals Inc|Page 6

Stay updated with breaking news from Navidea biopharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

StockNews.com Initiates Coverage on Navidea Biopharmaceuticals (NYSE:NAVB)

StockNews.com Initiates Coverage on Navidea Biopharmaceuticals (NYSE:NAVB)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Navidea Biopharmaceuticals Inc , Therapeutic Development Programs , Allred Capital Management , Renaissance Technologies , Navidea Biopharmaceuticals Company Profile , Navidea Biopharmaceuticals , Get Free Report , Capital Management , State Street Corp , Street Corp , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily ,

Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NYSE NAVB opened at $0.05 on Friday. The company has a market cap of $5.00 million, a PE ratio of -0.17 […] ....

Navidea Biopharmaceuticals Inc , Therapeutic Development Programs , Allred Capital Management , Renaissance Technologies , Navidea Biopharmaceuticals , Free Report , Get Free Report , Street Corp , Capital Management , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,

Navidea Biopharmaceuticals (NYSE:NAVB) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance NAVB stock opened at $0.05 on Friday. The company has a market capitalization of $5.00 million, a P/E ratio of -0.17 […] ....

Allred Capital Management , Navidea Biopharmaceuticals Company Profile , Navidea Biopharmaceuticals Inc , Therapeutic Development Programs , Renaissance Technologies , Navidea Biopharmaceuticals , Free Report , Get Free Report , Capital Management , Street Corp , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,